We bring you the latest news from the healthcare about the health care in the United Kingdom. Do your have news for us? Contact the editor. Watch also this special movie.

zaterdag 18 maart 2017

The Lancet: [Health Policy] Health workers and the weaponisation of health care in Syria: a preliminary inquiry for ...

[Health Policy] Health workers and the weaponisation of health care in Syria: a preliminary inquiry for –American University of Beirut Commission on Syria
The conflict in Syria presents new and unprecedented challenges that undermine the principles and practice of medical neutrality in armed conflict. With direct and repeated targeting of health workers, health facilities, and ambulances, Syria has become the most dangerous place on earth for health-care providers. The weaponisation of health care—a strategy of using people's need for health care as a weapon against them by violently depriving them of it—has translated into hundreds of health workers killed, hundreds more incarcerated or tortured, and hundreds of health facilities deliberately and systematically attacked.
Read more

[Editorial] Syria suffers as the world watches
March 1 5, 2017, marks the sixth anniversary of the civil war in Syria, a conflict perhaps unprecedented in its apparently shameless disregard for international law. The world has stood by in horror, watching the death toll rise and the humanitarian and refugee crises spread their indelible stain on the world map and human history. The Syrian conflict has been marked on the one hand by immense suffering and on the other by a stunning lack of adequate condemnation or action from governments, international agencies, or the medical community.
Read more

[Department of Error] Department of Error
Le Roux CW, Astrup A, Fujioka K, et al. 3 years of liraglutide versus placebo for type 2 diabetes risk reduction and weight management in individuals with prediabetes: a randomised, double-blind trial. Lancet 2017; published online Feb 22. http://dx.doi.org/10.1016/S0140-6736(17)30069-7—In table 1, some rounding errors in the percentages have been amended. In addition, the y-axis scale for figure 2C was incorrect. The y-axis scale has been amended to −0·6 to 2. These corrections have been made online as of March 14, 2017.
Read more

[Articles] Coronary atherosclerosis in indigenous South American Tsimane: a cross-sectional cohort study
Despite a high infectious inflammatory burden, the Tsimane, a forager-horticulturalist population of the Bolivian Amazon with few coronary artery disease risk factors, have the lowest reported levels of coronary artery disease of any population recorded to date. These findings suggest that coronary atherosclerosis can be avoided in most people by achieving a lifetime with very low LDL, low blood pressure, low glucose, normal body-mass index, no smoking, and plenty of physical activity. The relative contributions of each are still to be determined.
Read more

[Comment] GEMINI-ACS-1: toward unearthing the antithrombotic therapy cornerstone for acute coronary syndromes
The cornerstone of acute coronary syndrome therapy was firmly laid when ISIS-2 showed a 23% reduction in vascular death with aspirin versus placebo.1 The antithombotic effect of aspirin is largely explained by inhibition of COX 1, a central enzyme mediating platelet activation. This and pleotropic cardioprotective properties should be considered before forsaking or replacing aspirin, particularly early in the highly prothrombotic state of a new acute coronary syndrome (panel).2,3 The enhanced antithrombotic effect of combining aspirin with clopidogrel, an inhibitor of the P2Y12 receptor, another key pathway of platelet activation, revolutionised treatment of acute coronary syndromes.
Read more